Evidence map›Paper›PMID 23122189›Full record

ArticleInfluenza and other respiratory viruses2013

Statistical estimates of respiratory admissions attributable to seasonal and pandemic influenza for Canada.

Dena L Schanzer, Allison McGeer, Kathleen Morris

Registry-linked trialAbstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05290792 (Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections), which is not on this map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05290792 nacompletednot on this mapstarted 2021, after this paper: background citation

Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections: The WE SENSE Study

TypeinterventionalSponsorEmily McDonaldRan2021 to 2022Enrolled56ConditionsViral Respiratory Tract Infection, InfluenzaArmsAdministration of FluMist (Live Attenuated Influenza Vaccine)
3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2024-2025.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2024
    Article
  6. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2023-2024.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2022-2023.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Summary of the NACI Seasonal Influenza Vaccine Statement for 2020-2021.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dena L SchanzerInfectious Disease Prevention and Control Branch, Public Health Agency of Canada, Ottawa, ON, Canada. Dena.Schanzer@phac-aspc.gc.ca
Allison McGeer
Kathleen Morris

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe number of admissions to hospital for which influenza is laboratory confirmed is considered to be a substantial underestimate of the true number of admissions due to an influenza infection. During the 2009 pandemic, testing for influenza in hospitalized patients was a priority, but the ascertainment rate remains uncertain.

methodsThe discharge abstracts of persons admitted with any respiratory condition were extracted from the Canadian Discharge Abstract Database, for April 2003-March 2010. Stratified, weekly admissions were modeled as a function of viral activity, seasonality, and trend using Poisson regression models.

resultsAn estimated 1 out of every 6.4 admissions attributable to seasonal influenza (2003-April 2009) were coded to J10 (influenza virus identified). During the 2009 pandemic (May-March 2010), the influenza virus was identified in 1 of 1.6 admissions (95% CI, 1.5-1.7) attributed to the pandemic strain. Compared with previous H1N1 seasons (2007/08, 2008/09), the influenza-attributed hospitalization rate for persons <65 years was approximately six times higher during the 2009 H1N1 pandemic, whereas for persons 75 years or older, the pandemic rate was approximately fivefold lower.

conclusionsCase ascertainment was much improved during the pandemic period, with under ascertainment of admissions due to H1N1/2009 limited primarily to patients with a diagnosis of pneumonia.

Indexed as

AdolescentAdultAgedCanadaChildChild, PreschoolFemaleHospitalizationHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanMaleMiddle AgedPandemicsPatient AdmissionSeasonsCase ascertainmentdata analysisempirical researchhospital admissionsinfluenzaseasonal and pandemicstatistical models

Identifiers

PMID23122189
PMCPMC3796862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.